Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

October
07
2016

New study highlights need for routine skin cancer screening for all transplant patients

Drexel University College of Medicine study suggests all organ transplant recipients should receive total-body screenings for skin cancer

October
06
2016

Sensus Healthcare to Participate in Important Dermatological and Institutional Investor Conferences from October 20th to October 23rd

–2016 Fall Clinical Dermatology Conference in Las Vegas, NV –Dawson James 2016 Small Cap Growth Stock Conference in Jupiter, FL BOCA RATON, Fla., Oct. 6, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device…

September
29
2016

SRT-100™: A Painless, Non-Invasive, Non-Melanoma Skin Cancer Treatment Right in Your Office

Whether you are a radiation oncologist or a dermatologist, you can enhance your patient care with the SRT-100™ non-melanoma skin cancer treatment….
September
18
2016

SRT-100™: A Non-Melanoma Skin Cancer Treatment Your Body Can Handle, but Cancer Cannot

Skin cancer is the fastest growing cancer in the world. Experts predict the number of people diagnosed with non-melanoma skin cancer will grow to nearly six million by the year 2020. With the epidemic of…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy